Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3)

This study has been terminated.
(PI has re-located. PI terminated FDA IND # and closed study.)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Sonia Michail, MD, Children's Medical Center of Dayton Identifier:
First received: July 2, 2009
Last updated: March 16, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)